(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

EUROARRAY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

EUROARRAY

ST13

US500000087904724

Classe

1, 5, 9, 10

Pedido

87904724

Registro

6285552

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

10/03/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 10

Data de depósito

02/05/2018

Data de registro

09/03/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

09/03/2021

Última transação

10/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Lübeck, DE

Examinador

AURAND, KYLE C

Unidade examinadora

N80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

EUROIMMUN Medizinische Labordiagnostika AG

Representantes

Kevan L. Morgan SEED IP LAW GROUP LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Diagnostic preparationsdiagnostic agents and diagnostic substances for scientific purposesin particular immobilized proteinscells or viruses or components thereofnucleic acid sequencesbiomarker and biological tissue cultures on a carrier material in the nature of a biochip; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier

Classe 5

Diagnostic agentsin particular diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposesimmobilized proteinscells or viruses or components thereofnucleic acid sequencesbiomarker and biological tissue cultures on a support material in the nature of a biochip; Reagents for medical and veterinary diagnostics; Reagents for medical and veterinary diagnosticsimmobilized proteinscells or viruses or components thereofnucleic acid sequencesbiomarker and biological tissue cultures on a support material in the nature of a biochip; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier

Classe 9

Measuringdetecting and monitoring devicesmedical laboratory research instruments for preparingprocessing and evaluating diagnostic samples; Sensors and detectorsmedical laboratory research instruments for detecting UV fluorescence and chemiluminescence for preparingprocessing and evaluating diagnostic samples; Apparatuses for recordingtransmission and reproduction of diagnostic datasound and imagescamerasmicroscopesphotometersmicroplate photometersenzyme linked immunosorbent assay readersphotomultipliermicroplate readers; Laboratory software for recordingtransmitting and reproducing diagnostic datasound and images; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier

Classe 10

Medical apparatus and instruments for medical examinations and medical diagnosissample preparation devices for medical diagnostic usesin particular for determining neurological diseasesinfectious diseasesautoimmune diseasesallergies and cancer; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/03/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

09/03/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

22/12/2020

PUBO

PUBLISHED FOR OPPOSITION

22/12/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/12/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/11/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

13/11/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

13/11/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

13/11/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

13/11/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/11/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/11/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/11/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

21/08/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

21/08/2020

CNSI

SUSPENSION INQUIRY WRITTEN

21/08/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

21/02/2020

GNSL

LETTER OF SUSPENSION E-MAILED

21/02/2020

CNSL

SUSPENSION LETTER WRITTEN

21/02/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

21/02/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/02/2020

ALIE

ASSIGNED TO LIE

19/02/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

13/02/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

14/08/2019

GNSI

INQUIRY TO SUSPENSION E-MAILED

14/08/2019

CNSI

SUSPENSION INQUIRY WRITTEN

14/08/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/02/2019

GNSL

LETTER OF SUSPENSION E-MAILED

11/02/2019

CNSL

SUSPENSION LETTER WRITTEN

11/02/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/02/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/02/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/02/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

13/08/2018

GNRT

NON-FINAL ACTION E-MAILED

13/08/2018

CNRT

NON-FINAL ACTION WRITTEN

13/08/2018

DOCK

ASSIGNED TO EXAMINER

08/08/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/05/2018

NWAP

NEW APPLICATION ENTERED

05/05/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace EUROARRAY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.